FAB — Fusion Antibodies Share News
0.000.00%
Last trade - 00:00- £14.39m
- £14.53m
- £1.97m
Fusion Antibodies - OptiMAL collaboration agreement
Brief: Fusion Antibodies Anticipates Revenues For FY2024 To Be Significantly Weighted Towards Second Half Of Financial Year
Fusion Antibodies - Half year trading update
Brief: Fusion Antibodies Says FY Revenue Down 40% To 2.9 Mln Stg
Fusion Antibodies - Final Results
Brief: Fusion Antibodies Receives First Purchase Order For Its AI/Ml-AB(TM) Services
Brief: Fusion Antibodies Says Stephen Smyth Appointed As Interim CFO Of Co
Brief: Fusion Antibodies Provides Update On AI/Ml-AB™ Antibody Discovery Service
Fusion Antibodies - Update on AI/ML-Ab™ antibody discovery service
Brief: Fusion Antibodies Completes Restructuring Process To Reduce Annualised Costs By About £2.2 Mln
Fusion Antibodies - Update on restructure and cost savings
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Director/PDMR Shareholding
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Result of Retail Offer and Notice of GM